DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
Q4 2024 vs. Q3 2024
How the institutions holding DBV Technologies S.A. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 24 | 18 | −6 |
| SharesConverted for a 1-for-5 split | 3.22M | 2.74M | −480.4K (−14.9%) |
| Value | $11.3M | $8.46M | −$2.80M (−24.9%) |
New holders (4)
Institutions that held DBV Technologies S.A. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 162,376 | $501.7K | 0.00% |
| Boxer Capital Management, LLC | 50,000 | $154.5K | 0.01% |
| BNP Paribas Arbitrage, SA | 1,650 | $5.10K | 0.00% |
| Curio Wealth, LLC | 27 | $83 | 0.00% |
Sold out (10)
Institutions that held DBV Technologies S.A. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Braidwell LP | 1,630,542 | $1.14M |
| Boxer Capital, LLC | 250,000 | $175.0K |
| Millennium Management LLC | 213,716 | $149.6K |
| Citadel Advisors LLC | 34,468 | $24.1K |
| Old Mission Capital LLC | 26,884 | $18.8K |
| Cowen and Company, LLC | 19,768 | $13.8K |
| Geode Capital Management, LLC | 19,389 | $13.6K |
| Janney Montgomery Scott LLC | 11,773 | $8.00K |
| CoreCap Advisors, LLC | 6,739 | $4.72K |
| Cubist Systematic Strategies, LLC | 1 | $1 |